{"date":"2025-07-11","count":16,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6885-2025-07-11-2333-1mo75wp","company_id":"6885","company":"全福生技","market":"上市","industry":"生技醫療","date":"2025-07-11","time":"23:33:45","subject":"公告本公司開發中新藥BRM421治療乾眼症第II期劑量探索、安全性與療效性之人體臨床試驗(IND)已獲衛生福利部原則同意試驗進行","clause":"第10款","fact_date":"2025-07-11","cite_as":"公開資訊觀測站重大訊息：全福生技（6885），2025-07-11 23:33，「公告本公司開發中新藥BRM421治療乾眼症第II期劑量探索、安全性與療效性之人體臨床試驗(IND)已獲衛生福利部原則同意」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6762-2025-07-11-1819-1bophwm","company_id":"6762","company":"達亞","market":"上櫃","industry":"生技醫療","date":"2025-07-11","time":"18:19:10","subject":"114年第二季財務報告董事會預計召開日期為114年07月21日","clause":"第31款","fact_date":"2025-07-11","cite_as":"公開資訊觀測站重大訊息：達亞（6762），2025-07-11 18:19，「114年第二季財務報告董事會預計召開日期為114年07月21日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6891-2025-07-11-1817-1lh9jou","company_id":"6891","company":"樂迦再生","market":"興櫃","industry":"生技醫療","date":"2025-07-11","time":"18:17:10","subject":"（更正公告）公告本公司內部稽核主管異動","clause":"第11款","fact_date":"2025-07-11","cite_as":"公開資訊觀測站重大訊息：樂迦再生（6891），2025-07-11 18:17，「（更正公告）公告本公司內部稽核主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7827-2025-07-11-1759-xzhibp","company_id":"7827","company":"漢康-KY創","market":"上市","industry":"生技醫療","date":"2025-07-11","time":"17:59:53","subject":"更正本公司114年6月背書保證明細表資訊","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢康-KY創（7827），2025-07-11 17:59，「更正本公司114年6月背書保證明細表資訊」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7784-2025-07-11-1752-ooxfi2","company_id":"7784","company":"安邦生技*","market":"興櫃","industry":"生技醫療","date":"2025-07-11","time":"17:52:09","subject":"公告本公司第一屆薪資報酬委員會委員","clause":"第9款","fact_date":"2025-07-11","cite_as":"公開資訊觀測站重大訊息：安邦生技*（7784），2025-07-11 17:52，「公告本公司第一屆薪資報酬委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7784-2025-07-11-1742-ys9dpv","company_id":"7784","company":"安邦生技*","market":"興櫃","industry":"生技醫療","date":"2025-07-11","time":"17:42:30","subject":"本公司經理人解除競業禁止限制","clause":"第9款","fact_date":"2025-07-11","cite_as":"公開資訊觀測站重大訊息：安邦生技*（7784），2025-07-11 17:42，「本公司經理人解除競業禁止限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6891-2025-07-11-1716-p67uuk","company_id":"6891","company":"樂迦再生","market":"興櫃","industry":"生技醫療","date":"2025-07-11","time":"17:16:57","subject":"公告本公司內部稽核主管異動","clause":"第11款","fact_date":"2025-07-11","cite_as":"公開資訊觀測站重大訊息：樂迦再生（6891），2025-07-11 17:16，「公告本公司內部稽核主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6891-2025-07-11-1714-5rax5d","company_id":"6891","company":"樂迦再生","market":"興櫃","industry":"生技醫療","date":"2025-07-11","time":"17:14:32","subject":"公告本公司董事會決議員工認股權憑證轉換普通股增資基準日","clause":"第9款","fact_date":"2025-07-11","cite_as":"公開資訊觀測站重大訊息：樂迦再生（6891），2025-07-11 17:14，「公告本公司董事會決議員工認股權憑證轉換普通股增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6891-2025-07-11-1712-nadirc","company_id":"6891","company":"樂迦再生","market":"興櫃","industry":"生技醫療","date":"2025-07-11","time":"17:12:32","subject":"公告本公司董事會決議變更會計師事務所及簽證會計師","clause":"第7款","fact_date":"2025-07-11","cite_as":"公開資訊觀測站重大訊息：樂迦再生（6891），2025-07-11 17:12，「公告本公司董事會決議變更會計師事務所及簽證會計師」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6986-2025-07-11-1656-c2trgg","company_id":"6986","company":"和迅","market":"上櫃","industry":"生技醫療","date":"2025-07-11","time":"16:56:34","subject":"公告本公司公司治理主管任命案","clause":"第11款","fact_date":"2025-07-11","cite_as":"公開資訊觀測站重大訊息：和迅（6986），2025-07-11 16:56，「公告本公司公司治理主管任命案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6130-2025-07-11-1649-13fqnxr","company_id":"6130","company":"上亞科技","market":"上櫃","industry":"生技醫療","date":"2025-07-11","time":"16:49:56","subject":"公告本公司法人董事-星寶電子科技股份有限公司改派代表人","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：上亞科技（6130），2025-07-11 16:49，「公告本公司法人董事-星寶電子科技股份有限公司改派代表人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2025-07-11-1647-1180bcs","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2025-07-11","time":"16:47:27","subject":"公告本公司審計委員會異動名單","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2025-07-11 16:47，「公告本公司審計委員會異動名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6541-2025-07-11-1509-9od83q","company_id":"6541","company":"泰福-KY","market":"上市","industry":"生技醫療","date":"2025-07-11","time":"15:09:27","subject":"公告本公司訂定114年現金增資認股基準日等相關事宜(補充公告發行價格、代收及存儲價款銀行)","clause":"第11款","fact_date":"2025-07-11","cite_as":"公開資訊觀測站重大訊息：泰福-KY（6541），2025-07-11 15:09，「公告本公司訂定114年現金增資認股基準日等相關事宜(補充公告發行價格、代收及存儲價款銀行)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6612-2025-07-11-1434-1jatiio","company_id":"6612","company":"奈米醫材","market":"上櫃","industry":"生技醫療","date":"2025-07-11","time":"14:34:41","subject":"美國子公司 AST PRODUCTS, INC.接獲客戶授權合約展期通知","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：奈米醫材（6612），2025-07-11 14:34，「美國子公司 AST PRODUCTS, INC.接獲客戶授權合約展期通知」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4114-2025-07-11-1346-10jca0t","company_id":"4114","company":"健喬","market":"上櫃","industry":"生技醫療","date":"2025-07-11","time":"13:46:07","subject":"本公司受邀參加凱基證券舉辦之法人說明會","clause":"第12款","fact_date":"2025-07-22","cite_as":"公開資訊觀測站重大訊息：健喬（4114），2025-07-11 13:46，「本公司受邀參加凱基證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1784-2025-07-11-1008-1f195kl","company_id":"1784","company":"訊聯","market":"上櫃","industry":"生技醫療","date":"2025-07-11","time":"10:08:32","subject":"更正公告-公告本公司董事會決議買回本公司股份並辦理轉讓員工 (修訂「第七次買回股份轉讓員工辦法」)","clause":"第35款","fact_date":"2025-06-17","cite_as":"公開資訊觀測站重大訊息：訊聯（1784），2025-07-11 10:08，「更正公告-公告本公司董事會決議買回本公司股份並辦理轉讓員工 (修訂「第七次買回股份轉讓員工辦法」)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}